Glycaemic control and hypoglycaemia benefits with insulin glargine 300 U/mL extend to people with type 2 diabetes and mild-to-moderate renal impairment
2018 ◽
Vol 20
(12)
◽
pp. 2860-2868
◽
Keyword(s):
Keyword(s):
Keyword(s):
2017 ◽
Vol 20
(2)
◽
pp. 448-452
◽
Keyword(s):
2014 ◽
Vol 106
◽
pp. S31
◽
Keyword(s):
2020 ◽
Vol 22
(8)
◽
pp. 1369-1377
◽
Keyword(s):
2020 ◽
Keyword(s):
2020 ◽
Keyword(s):